Peter F. Coccia, MD, is the Ittner Professor and Vice-Chairman of the Department of Pediatrics, at the University of Nebraska Medical Center (UNMC) in Omaha.
Dr. Coccia received his medical degree from Upstate Medical Center where he also completed a predoctoral fellowship in biochemistry. His postgraduate training was in clinical pathology and hematopathology at Upstate and in pediatrics and pediatric hematology/oncology at the University of Minnesota. He served in the U.S. Public Health Service.
Dr. Coccia has been extensively involved in The Children’s Cancer Group/Children’s Oncology Group for more than 30 years as a PI and chairperson of numerous study committees and strategy groups. He is a member of the NCCN Board of Directors, and serves on the NCCN Guidelines Panels for Adolescent and Young Adult Oncology (Chair), Acute Lymphoblastic Leukemia, and Cancer- and Chemotherapy-Induced Anemia.
He is the author or coauthor of more than 170 peer-reviewed publications and more than 200 abstracts. His major clinical research areas have included the treatment of acute lymphoblastic leukemia and non-Hodgkin’s lymphomas in children and adolescents, and stem cell transplantation for inherited disorders, aplastic anemia, acute leukemia, and lymphomas.
The ideas and viewpoints expressed in this editorial are those of the author and do not necessarily represent any policy, position, or program of NCCN.